Life Sciences 360 is an interview show that educates anyone on challenges, trends, and insights in the life-sciences industry. Hosted by Harsh Thakkar, a life-sciences industry veteran and CEO and co-founder of Qualtivate, the show features subject-matter experts, business leaders, and key life-science partners contributing to bringing new therapies to patients worldwide. Harsh is passionate about advancements in life sciences and tech and is always eager to learn from his guests— making the ...
…
continue reading
In-depth analysis and breakdown of songs. This podcast would take a deeper look at the songs we love and listen to on a regular basis. Join me on this beautiful journey of exploring the depth of songs.
…
continue reading
The Punishers are a wheelchair basketball team based in Washington, D.C. These are their stories.
…
continue reading

1
What Separates Life Science Startup Winners from Losers?
38:46
38:46
Play later
Play later
Lists
Like
Liked
38:46Why Startups Fail (Hint: It’s Not the Innovation) In this episode, Carlo Odicino, CEO and Founder at One TEAM Partners, shares the real reasons why most early-stage life sciences companies struggle to survive—and it has nothing to do with bad science. Learn the hidden pitfalls of scaling too fast, confusing innovation with execution, and chasing to…
…
continue reading

1
Pandora's Box of Secrets EXPOSED in Drug Pricing Transparency!
30:15
30:15
Play later
Play later
Lists
Like
Liked
30:15The Hidden Math Behind Drug Pricing: Why Patients Pay More Than They Should In this episode, Michael Grosberg, VP of Product Management at Model N, breaks down the complex drug pricing ecosystem—revealing how rebates, PBMs, and outdated pricing models shape what patients actually pay. You’ll learn how Pharmacy Benefit Managers (PBMs) really operate…
…
continue reading

1
A CCO’s Brutally Honest Advice if You Want to Succeed in Pharma Commercialization
31:45
31:45
Play later
Play later
Lists
Like
Liked
31:45Early Commercialization Strategies That Actually Work (Especially for Startups!) In this episode, John Harlow, Chief Commercial Officer at Melinta Therapeutics, shares real-world strategies for how lean pharma startups can win the commercialization game—without Big Pharma budgets. Discover how small companies can pivot fast, creatively optimize dis…
…
continue reading

1
Digital Health Expert: THIS is the No.1 Roadblock to Healthcare AI Adoption
35:12
35:12
Play later
Play later
Lists
Like
Liked
35:12Healthcare AI adoption is transforming the way we address risk, confidentiality, and patient care. In this episode, RJ Kedziora, co-founder of Estenda Solutions talks about the practical steps to safely integrate AI in clinical workflows. Learn how to manage data privacy, mitigate algorithmic bias, and keep a human in the loop to prevent misdiagnos…
…
continue reading

1
Tired of Supply Chain Errors? Here’s the Fix: Drug Serialization for DSCSA Compliance
39:50
39:50
Play later
Play later
Lists
Like
Liked
39:50Drug serialization is at the heart of modern pharmaceutical supply chain security. In this episode Michael Rowe, Senior Director of DSCSA and Serialization Services at TwoLabs, talks about the critical role of drug serialization and DSCSA compliance in safeguarding the pharmaceutical supply chain. Michael explains how unique serial numbers, standar…
…
continue reading

1
Why Equitable Healthcare is the KEY to Better Health
22:03
22:03
Play later
Play later
Lists
Like
Liked
22:03Equitable healthcare is the key to bridging health gaps and creating better patient outcomes. In this episode, Amy West, Principal, Advisory Services at HitLab, share her insights on how technology, digital health, and data can reshape access to care—especially for underserved communities. Learn how addressing social determinants, using remote pati…
…
continue reading
Have you ever wondered if AI could help doctors find cancer faster and more accurately? In this episode, we explore OmniScreen, an AI-powered biomarker tool that is revolutionizing cancer diagnostics. Joe Oakley, a pathologist and expert in digital pathology, explains how OmniScreen was trained on 3 million digital slides to detect cancer biomarker…
…
continue reading

1
Why Science Marketing Will Make Your Company EXPLODE in 2025?
44:05
44:05
Play later
Play later
Lists
Like
Liked
44:05Have you ever wondered why marketing in the life sciences industry is so different from traditional marketing? In this episode, we dive deep into the power of science marketing, the impact of brand storytelling, and how companies can successfully position their products in a competitive market. From publishing content to collaboration with industry…
…
continue reading

1
Why Most New Drugs Don't Launch: The Hidden Challenges in Pharma
37:44
37:44
Play later
Play later
Lists
Like
Liked
37:44Have you ever wondered why so many new drugs fail even after years of research and billions in investment? In this episode, we dive deep into the challenges of drug commercialization, the role of AI in pharma, and the biggest mistakes companies make before going to market. Our guest, Dan Cummings, is a leading expert in go-to-market strategy, havin…
…
continue reading

1
Why 55% of Clinical Trials Fail – The Truth About Drug Development
43:51
43:51
Play later
Play later
Lists
Like
Liked
43:51Have you ever wondered why so many clinical trials fail before reaching the market? In this episode, we dive deep into the hidden challenges of clinical trials with Rob Freishtat, President and Co-Founder of Uncommon Cures and a professor at George Washington University School of Medicine and Health Sciences. Rob shares insider knowledge on why ove…
…
continue reading

1
How to Get Quick Access to GLP-1 Medications without Health Insurance ft. Dr. Jonathan Kaplan
41:10
41:10
Play later
Play later
Lists
Like
Liked
41:10In this episode of Life Sciences 360, we dive deep into the world of GLP-1 medications with Dr. Jonathan Kaplan. We discuss weight management, how these medications work, their impact beyond weight loss, and the ethical considerations surrounding their use. Dr. Kaplan shares his insights on the healthcare industry's evolving landscape, the economic…
…
continue reading

1
Astellas Pharma’s Approach to Cell and Gene Therapy
36:11
36:11
Play later
Play later
Lists
Like
Liked
36:11In this episode of LifeSciences 360, we dive into the fascinating world of cell and gene therapy manufacturing with Carlos Yuraszeck. With over 16 years of experience, Carlos shares his deep insights into the unique challenges, opportunities, and innovations in the field, offering a detailed look into what it takes to bring life-saving therapies to…
…
continue reading

1
ISPE’s Role in Shaping the Future of mRNA and Personalized Medicine
34:03
34:03
Play later
Play later
Lists
Like
Liked
34:03In this episode of Life Sciences 360, we dive into the evolution of pharmaceutical and biotech manufacturing with our guest, Scott, a seasoned expert with nearly 30 years of experience working with industry giants like Novartis, Biogen, Thermo Fisher, and Merck. Scott shares insights on cell culture technology, mRNA vaccines, and the challenges and…
…
continue reading

1
Balancing Leadership Roles in a High-Stakes Industry with Taggart McGurrin
30:00
30:00
Play later
Play later
Lists
Like
Liked
30:00Welcome to another episode of Life Sciences 360! Today, we're diving into the intricate world of life sciences leadership with a special guest who's worn nearly every hat in the industry—Taggart McGurrin. Starting in finance, transitioning to law, and tackling leadership roles across strategy, operations, and regulatory affairs, Taggart McGurrin br…
…
continue reading

1
Why Antimicrobial Resistance Is the Biggest Challenge in Public Health
41:08
41:08
Play later
Play later
Lists
Like
Liked
41:08In this episode of Life Sciences 360, host Harsh Thakkar sits down with Marc Sheetz, Associate Dean of Research at Midwestern University's College of Pharmacy, to discuss the growing concern of antimicrobial resistance and the field of pharmacometrics. Marc sheds light on how pharmacometrics is shaping the future of medicine by using predictive mod…
…
continue reading

1
The Secret to Better Medications: Standardizing Pharmacogenomics (PGx) Testing
29:59
29:59
Play later
Play later
Lists
Like
Liked
29:59Imagine knowing how your body will respond to a medication before you even take it! In this episode, Harsh Thakkar interviews Sarah Rogers, co-founder and president of the American Society of Pharmacovigilance (ASP) and an Assistant Professor at Texas A&M. Together, they dive deep into the fascinating world of pharmacogenomics—how your genetic make…
…
continue reading

1
Life Sciences Marketing Agency CEO on How to Combine Storytelling and Science for Impact
36:46
36:46
Play later
Play later
Lists
Like
Liked
36:46In this episode, Harsh Thakkar welcomes David Ormesher, CEO of CG Life, a leading marketing agency in the life sciences and pharmaceutical sectors. David shares over 30 years of experience in life science marketing and storytelling. From startups to large enterprises, CG Life helps companies blend complex science with compelling stories to resonate…
…
continue reading

1
Could Worms REALLY Be the Key to Curing Autoimmune Diseases?
29:08
29:08
Play later
Play later
Lists
Like
Liked
29:08In this episode, we dive deep into a fascinating topic worm-derived therapeutics with our special guest Andrea, the founder and CEO of Holoclara. Did you know that autoimmune and allergic diseases were rare before the 1900s? What changed? Andrea shares groundbreaking insights into how worms, which have lived inside humans for millions of years, sec…
…
continue reading

1
How Amprion’s Test is Changing ALS, Dementia, and Parkinson’s Disease Diagnosis
37:18
37:18
Play later
Play later
Lists
Like
Liked
37:18Learn how misfolded proteins trigger cascading effects in the brain, leading to these devastating conditions, and how early detection can change the trajectory of treatment. Whether you’re curious about ALS, Parkinson’s, Dementia, or the role of molecular diagnostics. In this insightful episode, we dive deep into the world of neurodegenerative dise…
…
continue reading

1
How Generative AI Finds Cures for Rare Diseases Faster
37:57
37:57
Play later
Play later
Lists
Like
Liked
37:57Welcome to episode 063 of Life Sciences 360. We dive deep into the groundbreaking role of AI in healthcare and life sciences with Shweta from Google Cloud. Learn how AI is accelerating drug discovery, enhancing patient care, and revolutionizing rare disease research. If you're passionate about the intersection of technology and health, this is a mu…
…
continue reading

1
3 Steps to Avoid Burnout and Thrive in Biopharma, from a Global Expert
35:57
35:57
Play later
Play later
Lists
Like
Liked
35:57Welcome to episode 062 of Life Sciences 360. In this episode, we dive into an engaging conversation with Tom, a seasoned consultant, on how to recognize the early signs of burnout, foster a healthy and innovative work environment, and implement agility in regulated industries. Tom shares practical strategies for leaders and consultants alike to mai…
…
continue reading

1
How Samsung Biologics Achieved 16 Top Pharma Partnerships as a CDMO
43:15
43:15
Play later
Play later
Lists
Like
Liked
43:15Welcome to episode 061 of Life Sciences 360. In this episode of Life Sciences 360, host Harsh Thakkar sits down with Kevin Sharp, Senior Vice President and Head of Global Sales at Samsung Biologics. They dive deep into the evolving CDMO industry, the importance of agility, innovation, and the strategic growth pillars that are driving success at Sam…
…
continue reading

1
Why the Top 1% are lonely- insights from Dr. Robyn Odegaard
36:17
36:17
Play later
Play later
Lists
Like
Liked
36:17Welcome to episode 060 of Life Sciences 360. In this episode of Life Sciences 360, host Harsh Thakkar sits down with Dr. Robin Odegaard, a high-performance business psychologist and professional confidant, to discuss the hidden struggles that come with success. They dive deep into topics like imposter syndrome, self-sabotage, complex priorities, an…
…
continue reading

1
The Science Behind Tome’s Programmable Genomic Integration Technology with CSO John Finn
43:30
43:30
Play later
Play later
Lists
Like
Liked
43:30Welcome to episode 059 of Life Sciences 360. In this episode of Life Sciences 360, Harsh Thakkar is joined by John Finn, Chief Scientific Officer at Tome Biosciences. John shares his inspiring journey of overcoming challenges, like his stutter, while making groundbreaking strides in gene therapy. They dive deep into Tome’s unique technology, PGI (P…
…
continue reading

1
Inside the Lab: How Singota Solutions Leads in Early-Stage Pharma Development
32:25
32:25
Play later
Play later
Lists
Like
Liked
32:25Welcome to episode 058 of Life Sciences 360. In this insightful episode of Life Sciences 360, hosted by Harsh Thakkar, we explore the dynamic world of Contract Development and Manufacturing Organizations (CDMOs) with Ryan Memmer, Manager of Quality Control and Product Development at Singota Solutions. Ryan shares his journey from working at large p…
…
continue reading

1
Bioidentical Hormone Replacement: A Deep Dive with Dr. Greg Brannon
38:19
38:19
Play later
Play later
Lists
Like
Liked
38:19Welcome to episode 057 of Life Sciences 360. In this special episode of Life Sciences 360, hosted by Harsh Thakkar, we dive into the fascinating world of bioidentical hormone replacement therapy (BHRT) with Dr. Greg Brannon, Medical Director and Founder of Optimalbio. Celebrating National Men's Health Education and Awareness Month, Dr. Brannon shar…
…
continue reading

1
How Green Elephant Biotech is making labs more sustainable with Joel Eichmann
38:36
38:36
Play later
Play later
Lists
Like
Liked
38:36Welcome to episode 056 of Life Sciences 360. Welcome to another episode of Life Sciences 360! In this episode, Harsh Thakkar is joined by Joel Eichmann, co-founder and managing director of Green Elephant Biotech. Green Elephant Biotech is a trailblazer in the biotech industry, focusing on sustainability and using plant-based materials to create inn…
…
continue reading

1
The Future of mRNA Therapies with Dr. Kate Broderick
34:16
34:16
Play later
Play later
Lists
Like
Liked
34:16Welcome to episode 055 of Life Sciences 360. In this episode of Life Sciences 360! In this episode, Harsh sits down with Dr. Kate Broderick, Chief Innovation Officer at Maravai Life Sciences. Dr. Broderick shares her journey from academia to leading innovation in the biotech industry, discusses the pivotal role of Clean Cap technology in COVID-19 v…
…
continue reading

1
Vector Labs CEO Lisa Sellers on Innovation, Leadership, and Mentorship
42:57
42:57
Play later
Play later
Lists
Like
Liked
42:57Welcome to episode 054 of Life Sciences 360. In this episode of Life Science 360 ,Today, we are thrilled to have Lisa Sellers, the CEO of Vector Labs, as our special guest. Lisa shares her incredible journey from working at big names like Thermo Fisher and 10x Genomics to leading Vector Labs, a trusted manufacturer of reagents and critical componen…
…
continue reading

1
Scientist on Epigenetic Tuning and Future Therapies at Tune Therapeutics
36:52
36:52
Play later
Play later
Lists
Like
Liked
36:52Welcome to episode 053 of Life Sciences 360. In this episode of Life Science 360, our host Harsh Thakkar sits down with Brian Cosgrove, Principal Scientist at Tune Therapeutics. Brian dives deep into the fascinating world of epigenetics and its role in developing therapies for complex diseases. He shares insights on how Tune Therapeutics is leverag…
…
continue reading

1
Breaking Down Barriers in Psychedelic Drug Development
42:22
42:22
Play later
Play later
Lists
Like
Liked
42:22Welcome to episode 052 of Life Sciences 360. In this episode, of Life Sciences as we dive into the fascinating world of psychedelic therapeutics with Dr. Sam Clark, the Chief Executive Officer of Terran Biosciences. Dr. Clark shares his journey of founding Terran Biosciences, motivated by the need for better treatment options for psychiatric and ne…
…
continue reading

1
From Genes to Treatments: Howard McLeod on Precision Medicine
41:14
41:14
Play later
Play later
Lists
Like
Liked
41:14Welcome to episode 051 of Life Sciences 360. We welcome Howard McLeod, a distinguished expert in precision medicine and pharmacogenomics. Howard shares his profound journey into the world of personalized medicine, emphasizing the significant impact of individualized treatments on cancer patients. From groundbreaking gene discoveries to advising cut…
…
continue reading

1
Tony Martignetti on Inspired Leadership, Flashpoints, and Divergent Thinking
42:25
42:25
Play later
Play later
Lists
Like
Liked
42:25Welcome to episode 050 of Life Sciences 360. In this episode, Harsh Thakkar chats with Tony Martignetti, a top leadership development voice on LinkedIn and an advisor to numerous tech and life sciences executives. Tony shares his insights on inspired leadership, the importance of investing in people, and how to unlock potential within teams. They a…
…
continue reading

1
Understanding Drug Pricing and the Impact of the Inflation Reduction Act with Jesse Mendelsohn
39:21
39:21
Play later
Play later
Lists
Like
Liked
39:21Welcome to episode 049 of Life Sciences 360. In this episode of Life Sciences 360, host Harsh Thakkar welcomes Jesse Mendelsohn, Senior Vice President at Model N. Jesse delves into the intricacies of revenue optimization and compliance within the pharmaceutical industry. He shares insights on how Model N's platform aids pharmaceutical companies in …
…
continue reading

1
How DoseMeRx is Transforming Patient Care
33:21
33:21
Play later
Play later
Lists
Like
Liked
33:21Welcome to episode 048 of Life Sciences 360. In this episode, Sharmeen discuss the current one-size-fits-all approach in healthcare and the need for precision dosing. Sharmeen explains how DoseMe platform simplifies complex dosing methods at the bedside, benefiting both clinicians and patients. Sharmeen also touch on the integration with electronic…
…
continue reading

1
How InVision helps you make drug development decisions? #lifesciences
40:12
40:12
Play later
Play later
Lists
Like
Liked
40:12Welcome to episode 047 of Life Sciences 360. In this video, We discuss the importance of using AI in decision making in the life sciences industry. Ben highlight the need for evidence-based decision making and the challenges of finding relevant information in a sea of data. Ben introduce InVision, a platform that helps biotech and pharma companies …
…
continue reading

1
How CTMC is Changing Medicine Manufacturing
37:09
37:09
Play later
Play later
Lists
Like
Liked
37:09Welcome to episode 046 of Life Sciences 360. On this episode, Harsh discuss the intersection of luck and preparation in finding opportunities, particularly in the field of cell therapy. Harsh share insights from his conversation with Dr. Jason Bock, founder and CEO of CTMC, about the advancements and challenges in autologous cell therapies. We delv…
…
continue reading

1
AI in Life Sciences: Should You Follow This Trend?
41:58
41:58
Play later
Play later
Lists
Like
Liked
41:58Welcome to episode 045 of Life Sciences 360. On this episode, Nagesh Nama and his team at XLM talk on why Gen.AI is essential in the software test world and share examples of its use in various industries, particularly in life sciences and manufacturing. They address the challenges faced by companies in adopting AI and provide solutions for integra…
…
continue reading

1
The NASA Scientist Who Changed Cancer Diagnostics Forever
37:52
37:52
Play later
Play later
Lists
Like
Liked
37:52Dr. Arnon Chait, CEO of Cleveland Diagnostics, discusses his transition from NASA to the healthcare innovation space and the development of cancer diagnostics. Dr. Chait emphasizes the importance of using diagnostic advancements to strike a balance between over-screening and under-treating, particularly in the workup of cancer after failed screenin…
…
continue reading

1
How On-Demand Cleanrooms Can Speed Up Drug Development
28:24
28:24
Play later
Play later
Lists
Like
Liked
28:24With the market estimated to reach $11.5 billion by 2028. Clean Rooms on Demand is providing flexible and cost-effective solutions for biotech and pharma companies. The benefits of using clean rooms on demand include avoiding the high capital outlay and ongoing operational expenses of building and maintaining their own facilities, as well as the fl…
…
continue reading

1
Beyond the Pill: When Medicine Meets Mindset with CEO, Will Hind
30:39
30:39
Play later
Play later
Lists
Like
Liked
30:39How can behavioral science optimize pharmaceutical practices? Episode 042: Will Hind, CEO of Alpharmaxim Healthcare Communications, discusses the challenges and opportunities in integrating behavioral science with pharma strategies. Find out how this can lead to better patient outcomes and more tailored healthcare solutions. ----- Links: *Will Hind…
…
continue reading

1
The 3 Most Important Pillars of a Next-Generation CDMO, Explained!
34:01
34:01
Play later
Play later
Lists
Like
Liked
34:01Episode 041: J.D. Mowery, President and CEO of KBI Biopharma, discusses his career journey and the role of CDMOs in the biotech and pharma industry. He emphasizes the importance of relationships, risk-taking, and continuous learning in his career success. J.D. highlights the unique combination of expertise required to work in both biotech and CDMO …
…
continue reading

1
Use This Tech, Transform Science: Flow Meters w/ Bethany Silva
20:50
20:50
Play later
Play later
Lists
Like
Liked
20:50Are you interested in how the latest flow technology is transforming biopharmaceutical manufacturing? Join us for Episode 40 of the Life Sciences 360 podcast, where Harsh Thakkar (@harshvthakkar), CEO of Qualtivate sits down with Bethany Silva (@bethany-silva), Life Sciences Industry Manager at Endress+Hauser. They delve deep into the world of flow…
…
continue reading

1
Democratizing Cell Therapy: A PhD's Quest to Change Medicine Forever
32:05
32:05
Play later
Play later
Lists
Like
Liked
32:05Toon Lambrechts, co-founder of MyCellHub, shares his journey in democratizing access to cell and gene therapy. He discusses the challenges in cell therapy manufacturing, including the high costs and complex logistics. MyCellHub aims to reduce manufacturing costs and automate processes to make cell therapies more affordable and accessible. Toon emph…
…
continue reading

1
No Vision, No Problem: How Aaron Golub Redefined Possible
19:04
19:04
Play later
Play later
Lists
Like
Liked
19:04Aaron Golub, a consultant and speaker, shares his story of overcoming adversity as a legally blind athlete and ex-NFL free agent. He discusses his journey from being a third-string high school athlete to becoming the first legally blind Division I athlete. Aaron also talks about his transition from sports to a career in finance and eventually to co…
…
continue reading

1
His Strategy and Success Story with the MedTech Startup: FastWave
26:06
26:06
Play later
Play later
Lists
Like
Liked
26:06He scaled his business from 0 to 20 million in under 3 years. Get inspired by the story of Scott Nelson's strategic brilliance and entrepreneurial triumph with Joovv and FastWave Medical, a groundbreaking MedTech startup reshaping the industry landscape. Learn about the strategic decisions, challenges overcome, and pivotal moments that defined Scot…
…
continue reading

1
How SHE is Improving Patient Care with AI Enhanced Medical Devices
27:33
27:33
Play later
Play later
Lists
Like
Liked
27:33Weronika discusses the importance of integrating software with other systems for success and touches on various challenges such as data integration, user needs, and documentation practices. She highlights the evolving role of AI and software in healthcare, emphasizing patient-centered solutions and the importance of continuous learning in the Med-T…
…
continue reading

1
Employee Mental Health is VITAL to Success in ANY Business
31:51
31:51
Play later
Play later
Lists
Like
Liked
31:51Heather talks about the role of art in quality and documentation, challenges with document control methods, and her experience writing an article for Quality Magazine. She shares advice for entering the life sciences industry and the role of mentors in career development. Harsh and Heather also address the importance of mental health for leaders, t…
…
continue reading

1
Why Quality Assurance is More Than Just Following the Rules with Kimberly Wallbank
25:56
25:56
Play later
Play later
Lists
Like
Liked
25:56Episode 034: Harsh Thakkar (@harshvthakkar) interviews Kimberly Wallbank (@kimberlywallbank), the Principal Consultant at Quality Systems Services, LLC. Kimberly addresses the evolution of quality and regulatory practices, particularly the increased focus on risk assessment. She discusses the challenges companies face with compliance and the need f…
…
continue reading

1
The Intersection of Science and Art: How Chijindu is Bridging the Gap
17:05
17:05
Play later
Play later
Lists
Like
Liked
17:05Episode 033: Harsh Thakkar (@harshvthakkar) interviews Chijindu E. O. (@chijindu-authorceco), the Founder & Creative Director of Ceco Creations. Chijindu shares his journey in the field of science and art, starting with creating cartoons and animations to inspire and educate people, noting that visual appeal and creativity can make scientific conte…
…
continue reading